Mycobacterium bovis bacillus Calmette-Guérin (M. bovis BCG) is the only vaccine available against 13 tuberculosis (TB). This study reports on an integrated genome analysis workflow for BCG, resulting in the 14 completely assembled genome sequence of BCG Danish 1331 (07/270), one of the WHO reference strains 15 for BCG vaccines. We demonstrate how this analysis workflow enables the resolution of genome 16 duplications and of the genome of engineered derivatives of this vaccine strain. 17
genetic populations for BCG Danish 1331 have been described, which differ in the SenX3-RegX3 region 48 (having 2 or 3 repeats of 77 bp) 10 . For BCG Danish 1331 07/270 we document only 3 repeats of 77 bp 49 (Suppl. Fig. 2) . Two features described by Abdallah et al. 8 to be determinative for BCG Danish were not 50 identified, namely the rearrangement of the fadD26-pssA gene region and a 894 bp del in Mb0096c-51
Mb0098c. In addition, a 399 bp instead of 118 bp insertion was detected in leuA, giving 12 direct repeats of 52 57 bp, as in the Pasteur strain (previously denoted as S-RD13 11 ). These differences are likely due to inherent 53 repeat structures in these regions, which cannot be resolved by short sequencing reads (as used in Abdallah 54 et al. 8 ), but require long sequencing reads, as generated by PacBio SMRT sequencing in this study. 55
Two large tandem chromosomal duplications characterize the BCG strains; the DU2 and DU1 (Fig. 2, Suppl . 56 Table 6 ). While four different forms of the DU2 exist, the DU1 is supposed to be exclusively present in BCG 57 Pasteur [11] [12] [13] ; it spans the chromosomal origin of replication or oriC (dnaA-dnaN region) and encodes key 58 components of the replication initiation and cell division machinery. Surprisingly, we detected a DU1-like 59 duplication of 14,577 bp in BCG Danish (Fig. 1) . To adapt an unambiguous terminology, we considered all 60 duplications spanning the oriC as DU1, while specifying the strain in which the duplication was found. 61
Investigation of other publicly available data for BCG Danish did not show presence of a DU1 (Fig. 1c, Suppl . 62 DU1 presence/absence were detected by reanalyzing publicly available data (Fig. 1c, Suppl. Fig. 1 ). In 65 contrast to the literature, we detected BCG Pasteur substrains with a DU1 (data ref 13 ) and without a DU1 66 (data ref 8, 14 ). Similarly, experimental analysis of our in-house Pasteur strains (1721, 1173 ATCC 35734) 67 showed absence of a DU1 (Fig. 1d) . Additionally, a DU1-China was detected (data ref 7,13 ), but not in the 68 data of Abdallah et al. 2015 8 , which could be explained by the use of two different substrains of BCG that 69 are both named BCG China 8 . DU1-Birkhaug was consistently detected in all reported sequencing data of 70 that BCG strain. The genealogy of BCG strains is thus further complicated by the genomic instability of the 71 oriC during in vitro cultivation (Fig. 2, Suppl . Table 6 ). A DU1-like duplication has also been identified in a 72 'non-vaccine' strain; in a clinical isolate (3281), identified as BCG, a 7-kb region that covered six genes and 73 crossed the oriC was repeated three times 15 , further indicating that this region is prone to duplication. 74
Together, these data underline the importance of the genomic characterization of BCG strains used as 75 vaccines, including their dynamic duplications. 76
To demonstrate how this genome analysis methodology contributes to full characterization of improved 77 BCG-derived engineered vaccines, we applied it to a knock-out mutant (KO) for the sapM secreted acid 78 phosphatase, located in the analytically challenging long duplication region DU2 11 . Our BCG genome 79 analysis workflow unequivocally demonstrated that the KO engineering had inadvertently out-recombined 80 one of the copies of this DU2 and had given rise to a single SNP (Suppl. Fig. 4 , Suppl. Table 1 and 5). Such 81 unexpected genomic alterations are likely common in engineered live attenuated TB vaccines, but have so 82 far gone unnoticed due to lack of a complete reference genome and or suitable genome analysis 83 methodology. 84
The implementation of both short (Illumina) and long (PacBio) sequencing reads in one genome analysis 85 methodology allows the straightforward generation of completely assembled genomes of BCG strains. 86
These include the decomposition of the analytically challenging long duplications regions DU1 and DU2, 87 wherefore one formerly needed additional experimental methods (e.g. gap closure via PCR 15 ). 88
The availability of the complete reference genome for BCG Danish 1331 as well as the associated genome 89 analysis workflow, now permits full genomic characterization of (engineered) TB vaccine strains, which 90 should contribute to more consistent manufacturing of this highly cost-effective vaccine that protects the 91 world's newborns from disseminated TB. 92 The exact sequence of the DU1 region was based on a second round of local de novo assembly (SPAdes 180 v3.9.0) using soft-clipped Illumina reads surrounding the draft DU1 region where the Illumina read 181 coverage is more than two times higher than the background coverage. The Determination of the average relative quantities was performed using the qbasePLUS software (Biogazelle). 216
All results were normalized using the reference genes 16S rRNA, nuoG and mptpB. 217
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Dresden) for the PacBio library prep and sequencing services. We thank Insight Genomics Inc. (Tainan, 222 Taiwan) for the Illumina library prep and sequencing services. We thank the VIB Genetics Service Facility, 223 capacitance 25 µF). The cells were diluted with 1 ml of 7H9-ADS-Tw (pre-warmed at 37°C) after which 4 ml medium 331 was added and the culture was placed overnight at 37°C. The culture was plated out on 7H10 with 50 µg/ml 332 kanamycin and 50 µg/ml X-gal. The one blue colony (presence of lacZ) that was formed, was tested with colony PCR 333 for the integration of the plasmid and grown in liquid 7H9 medium without kanamycin to stimulate a second 334 homologous recombination, resulting in knocking out the sapM gene. To select for the clones that have lost the 335 plasmid, the culture was plated on 7H10 + 2% sucrose + 50 µg/ml X-gal (presence of sacB which inhibits growth on 336 sucrose medium). Several white colonies were tested for the absence of sapM, by means of PCR. One clone was 337 selected for further work, which showed absence of SapM expression and thus lost both sapM loci (Suppl. Fig. 4b ).
338
This was confirmed by PCR, Southern Blot, copy number analysis via qPCR, qPCR-RT analysis, SapM ELISA and 339 phosphatase assay (Suppl. Fig. 4c-i) . The SapM ELISA and phosphatase assay were performed as described in ref 
350
The expected Southern Blot band for the WT was 2206 bp and 1598 bp for the sapM KO (Suppl. Fig. 4c ).
352
were washed once with sterile water containing 0.5% Tween-80. The pellet was then resuspended in 500 µl of RLT 355 buffer (RNeasy Mini Kit, Qiagen; supplemented with β-ME). The cells were disrupted with glass beads in a Retsch 356 MM2000 bead beater at 4°C in screw-cap tubes (pre-baked at 150°C). After centrifugation (2 min, 13,000 rpm, 4°C), 357 the supernatant was transferred to a fresh eppendorf tube. To recover the lysate trapped in between the beads, 800 358 µl of chloroform was added to the beads and centrifuged, after which the upper phase was transferred to the same 359 eppendorf tube as before. Then, 1 volume of Acid Phenol/Chloroform (Ambion) was added, incubated for 2 minutes 360 and centrifuged (5 min, 13,000 rpm, 4°C). The upper aqueous phase was transferred to a fresh eppendorf tube and 361 this last step was repeated once. An equal volume of 70% ethanol was added and the sample was transferred to an 362 RNeasy spin column (RNeasy Mini Kit, Qiagen). The kit manufacturer's instructions were followed to purify the RNA. 
